Product
CAS
Specification
Documents
Phloroglucinol anhydrous
108-73-6
EP Specification
EDMF, Written confirmation
Phloroglucinol Dihydrate
6099-90-7
EP Specification
CEP/EDMF, Written confirmation
Vidarabine monophosphate
29984-33-6
CP
APIMF
Creatine Phosphate Sodium
922-32-7
CP
Written confirmation
Piribedil
3605-01-4
CP
Written confirmation
Moxifloxacin
151096-09-2
In-house
Technical Package
Guanfacine Hydrochloride
29110-48-3
CP
Written confirmation
Fomepizole
7554-65-6
CP
Written confirmation
Nitisinone
104206-65-7
CP
Written confirmation
Epalrestat
82159-09-9
CP
Written confirmation
Nafamostat Mesilate
82956-11-4
CP
CEP、Written confirmation
Doxofylline
69975-86-6
CP
CEP、Written confirmation
Copper-8-hydroxyquinoline
10380-28-6
Any Products under parent listted here solely for the permitted purpose,usage and behaviors in accordance with applicable patent Law and regulations in relevant countries.No commercial,sale or other behaviors prohibited by law will be taken or accepted before the expiration of the parent in relevant country.The customers shall evaluate the patent status of the products and be responsible for patent infringement.
